Market Place
Sourcing Support
Essential Role of Intellectual Property in Pharmaceutical API Company
15 Nov 2024 //
PRESS RELEASE
Neul& Laboratories Q2 FY25 consolidated PAT falls to Rs. 32.84 Cr
08 Nov 2024 //
INDPHARMAPOST
Achieving Drug Development Success: Neuland’s Three-Pillar Strategy
03 Oct 2024 //
PRESS RELEASE
Inside Neuland’s Three-Pillar Project Management Strategy
03 Oct 2024 //
PRESS RELEASE
Securing Sustainability in Pharma Supply Chain – Sucheth Davuluri
01 Oct 2024 //
PRESS RELEASE
Defining New Rules – The Evolution of the CDMO Industry – Saharsh
02 Sep 2024 //
PRESS RELEASE
From the Neuland Reading Room: Peptide Trends in 2024
02 Sep 2024 //
PRESS RELEASE
Zero Liquid Discharge: Pharma Industry Commitment To Sustainability
02 Aug 2024 //
PRESS RELEASE
Zero Liquid Discharge: A Pharma Industry Commitment to Environment
02 Aug 2024 //
PRESS RELEASE
Neuland Labs Q1FY25
17 Jul 2024 //
PRESS RELEASE
The Pharma Supply Chain: Reshaping Itself for The New Normal
03 Jul 2024 //
PRESS RELEASE
Pharma Supply Chain: Reshaping Itself for The New Normal
03 Jul 2024 //
PRESS RELEASE
Neuland unveils its dynamic new brand identity reinforcing
10 Jun 2024 //
PRESS RELEASE
Neuland unveils refreshed brand identity
07 Jun 2024 //
PRESS RELEASE
Neuland Laboratories Q4 FY24 Earnings Conference Call May 14, 2024
14 May 2024 //
PRESS RELEASE
A Check-in on 2024 Trends in the CDMO Industry
02 May 2024 //
PRESS RELEASE
Goldman Sach initiates `buy` on Syngene, Neuland, adds `sell` tag to Larus Lab
11 Apr 2024 //
MONEYCONTROL
How to Ensure Effective Technology Transfer to CDMOs
28 Mar 2024 //
PRESS RELEASE
Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility
25 Mar 2024 //
MONEYCONTROL
Neuland Labs Unit I Plant Passes USFDA Audit With Zero 483 Observations Again
24 Mar 2024 //
PRESS RELEASE
Why Agility Matters When Choosing an API Contract Manufacturing Partner
04 Mar 2024 //
PRESS RELEASE
Neuland Laboratories Q3 & 9M FY24 Earnings Conference Call” February 09, 2024
13 Feb 2024 //
LIVE MINT
Neuland Q3FY24 income
09 Feb 2024 //
PRESS RELEASE
Board Meeting Outcome Unaudited Q3 FY2023-24 Financial Results
08 Feb 2024 //
PRESS RELEASE
API Particle Size Part 2: New & Emerging Technologies Impacting Particle Size
01 Feb 2024 //
PRESS RELEASE
Unaudited Financial Results (Consolidated and Standalone) for Q2 FY 2024
07 Nov 2023 //
PRESS RELEASE
Unaudited Financial Results (Consolidated and Standalone) for Q1 FY 2024
03 Aug 2023 //
PRESS RELEASE
Neuland Lab Consolidated June 2023 Net Sales at Rs 362.99 crore, up 64.12% Y-o-Y
03 Aug 2023 //
MONEY CONTROL
Neuland Labs Share Jumps 44% in 3 Days on Strong Q4 Results
15 May 2023 //
EQUITYPANDIT
Neuland Laboratories appoints Abhijit Majumdar as CFO
24 Nov 2022 //
INDIANPHARMAPOST
End-to-End Focus on Quality in API Manufacturing
31 Oct 2022 //
PRESS RELEASE
Ensuring Rock-Solid IT Infrastructure in Contract Manufacturing
30 Sep 2022 //
PRESS RELEASE
Neuland Annual Report FY 2021-22
27 Sep 2022 //
PRESS RELEASE
SE Intimation – Resignation of Chief Financial Officer
13 Sep 2022 //
PRESS RELEASE
3 Key Elements of a Successful Hydrogenation Scale-Up
30 Aug 2022 //
PRESS RELEASE
Pharma Industry Zeroes in on Drug Manufacturing Sustainability
31 Jul 2022 //
PRESS RELEASE
A Novel Method of Manufacturing Alcaftadine
29 Jun 2022 //
PRESS RELEASE
Selecting Regulatory Starting Materials: A Q&A With Neuland’s Senior VP
29 Apr 2022 //
PRESS RELEASE
100 Years of Learning from Pharmaceutical Impurities
18 Mar 2022 //
PRESS RELEASE
Real-Time Remote GMP Inspections by Key Regulatory Agencies
07 Mar 2022 //
PRESS RELEASE
Green Generic Drug Subs: Increased Upfront Costs Offset Long-Term Profitability
31 Jan 2022 //
PRESS RELEASE
Exploring Neuland’s Therapeutic Segments: Focus on CNS
14 Jan 2022 //
PRESS RELEASE
Green Chemistry by Design (GCbD): The Earlier, The Better for Pharma APIs
03 Jan 2022 //
PRESS RELEASE
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy`s at new highs
17 Sep 2020 //
BUSINESS STANDARD
Neuland Labs receives EIR from US FDA for Pashamylaram facility
07 May 2020 //
PHARMABIZ
Neuland Labs` Pashmylaram facility gets 2 observations from US FDA
11 Feb 2020 //
PAHRAMBIZ
Neuland Labs` Pashmylaram facility gets 2 observations from US FDA
11 Feb 2020 //
PAHRAMBIZ
Neuland Labs gets 5 observations from USFDA for Unit 1 of Bonthapally plant
21 Jun 2019 //
MONEYCONTROL
Neuland Laboratories acquires Arch Pharma Labs
12 Dec 2017 //
INDIAINFOLINE
Neuland Laboratories Unveils Dedicated Process Engineering Lab
20 Jul 2017 //
PRESS RELEASE
US regulator makes 2 observations at Neuland Labs` facility
10 Apr 2017 //
ECONOMIC TIMES
No-Compromise APIs
08 Nov 2016 //
PHARMA MANUFACTURING
Neuland Labs reports another successful FDA audit & wins 2015 CMO award
26 Jan 2015 //
PRESS RELEASE
Neuland to Invest Rs. 300-cr in Next 4 Years to Double its Revenues
31 Dec 2014 //
PHARMABIZ
Neuland Labs` track record of cGMP excellence complemented by 2013 CMO
16 Aug 2014 //
PRESS RELEASE
Neuland Labs inaugurates new mfg facility collaboration Mitsubishi Healthcare
08 Apr 2014 //
PRESS RELEASE
